130 likes | 299 Views
Chris Town. Chief Executive Greater Peterborough Primary Care Partnership Chair, New Contractual Framework for Community Pharmacy Negotiating Group The Implications and Milestones of the New Contractual Framework. A Vision for Pharmacy in the new NHS - Community Pharmacy.
E N D
Chris Town Chief Executive Greater Peterborough Primary Care Partnership Chair, New Contractual Framework for Community Pharmacy Negotiating Group The Implications and Milestones of the New Contractual Framework
A Vision for Pharmacy in thenew NHS - Community Pharmacy • An integral part of the NHS • Planning and delivering local services • Supporting self-care • Responding to diverse needs of patients & communities • A Source of innovation in delivery of services • Helping to deliver aspirations in NSFs • Helping to tackle health inequalities
A Proposed New Contractual Framework for Community Pharmacy • Why change? • Current arrangements in place for nearly two decades • Need a framework that better reflects modern service requirements • Community pharmacy is an integral part of NHS services • What changes? • More flexible/versatile, with focus on higher quality services, less on prescription volume • Essential, advanced and enhanced/local services • Better fit with PCT role in developing local service provision
New Pharmacy Contractual Framework:Benefits • Improved patient choice & convenience • eg repeat dispensing and ETP • 24/48 hr access target • eg minor ailment schemes • Reducing demand on GPs • eg pharmacy led clinics - diabetes
New Pharmacy Contractual Framework:Benefits • Chronic disease management • eg medication review, supplementary prescribing, monitoring through near patient testing • Supporting delivery of nGMS • quality targets, OoHs, enhanced services • Health inequalities & public health • eg drug misuse, smoking cessation
New Pharmacy Contractual Framework:Benefits • Improved patient safety • eg learning from patient incidents • Better value for money • improved prescribing, reduced waste • medication review: £2 saved for every £1 invested • repeat dispensing : £2.60 - £10.00 saved per patient per month
Pharmacy Contract – Timetable • Contract specifications agreed between all parties to the negotiation • Three different categories – Essential, Advanced and Supplementary/Enhanced services • Negotiation completed re funding levels • PSNC consultation 92.5% voted in favour • Implementation April 2005
ETP & Better Pharmacy IM&T • ETP – electronic transmission of prescriptions between prescriber, dispenser and PPA • Read/write access to the patient record • Connectivity – e-mail/internet eg NeLH, NPSA, • Sharing of patient information is sensitive. • concerns of patients and others • the importance of patient consent • maintaining confidentiality during data access and transfer
ETP & Better Pharmacy IM&T • Discussing with stakeholders need for pharmacists to have access to patient records • Role based access • Inform consultation on elements of patient information that community pharmacists may need to deliver appropriate healthcare services as part of the proposed new contract • Consult shortly • Implementation timescale match new contract
New Pharmacy Contractual Framework: Implementation • Reflect & link to nGMS • Policy collaborative • Stakeholder engagement • NHS Modernisation Agency & NatPaCT • Refocus Medicines Management Collaborative • NPC & CPPE
What are we Doing Locally to Prepare? • Have set up a strategy group • Expanding existing community pharmacy schemes (Pharmacy First) in accordance with local needs • Pathfinder site for repeat dispensing – 2 practices involved locally • Looking at local service provision and where gaps are – needs assessment
What are we Doing Locally to Prepare? • Setting up a register of all pharmacists working locally, including locums • Attendance and feedback at PEC and LPC • Pharmacy service provision needs to go into LDP • Learning needs being identified and standardised competency assessments being carried out
Implications for the Pharma Industry • Pharmacists as prescribers - both independent and supplementary ? • Will this lead to more POM to P switches ? • Greater role for Pharmacists in Chronic disease management ? • Impact of medication reviews ? • Formulary development as part of closer links with G.P’s ?